OGN - Organon & Co.
6.9
-0.290 -4.203%
Share volume: 2,627,508
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$7.19
-0.29
-0.04%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-28-2025 | 05-02-2025 | 11-10-2025 | 02-24-2026 | |
| Total revenue | 1.592 B | 1.513 B | 1.602 B | 1.507 B | |
| Cost of revenue | 696.000 M | 672.000 M | 745.000 M | 766.000 M | |
| Gross profit | 896.000 M | 841.000 M | 857.000 M | 741.000 M | |
| -6.14% | 1.90% | -13.54% | |||
| Operating expenses | 600.000 M | 522.000 M | 499.000 M | 524.000 M | |
| Selling general and admin | 470.000 M | 420.000 M | 415.000 M | 433.000 M | |
| Research and development | 130.000 M | 102.000 M | 84.000 M | 91.000 M | |
| Total expenses | 608.000 M | 608.000 M | 499.000 M | 832.000 M | |
| 0.00% | -17.93% | 66.73% | |||
| Operating income | 288.000 M | 233.000 M | 358.000 M | -91.000 M | |
| Ebit | 282.000 M | 237.000 M | 371.000 M | -39.000 M | |
| Pretax income | 129.000 M | 101.000 M | 243.000 M | -148.000 M | |
| -21.71% | 140.59% | -160.91% | |||
| Income tax | 20.000 M | 14.000 M | 83.000 M | 57.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 109.000 M | 87.000 M | 160.000 M | -205.000 M | |
| -20.18% | 83.91% | -228.13% |